1-7 of 7
James L. Zehnder
Close
Sort by
Journal Articles

Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations

Haiyu Zhang, May Chien, Yu Hou, William Shomali, Rondeep S. Brar, Chandler Ho, Panpan Han, Danfei Xu, Bing M. Zhang, Xiangqian Guo, Lorna L. Tolentino, Nancy C. Wu, Albert G. Tsai, Jing Jin, Wesley H. Witteles, Zhenping Chen, Parveen Abidi, Diwash Jangam, Madison S. Krieger, Morgan Craig, James B. Bussel, Jason R. Gotlib, James L. Zehnder
Journal: Blood Advances
Blood Adv (2023) 7 (1): 190–194.
https://doi.org/10.1182/bloodadvances.2021006701
Published: 2023
Includes: Supplemental data
Journal Articles

Pembrolizumab in mycosis fungoides with PD-L1 structural variants

Clinical Trials & Observations
Sara Beygi, Sebastian Fernandez-Pol, George Duran, Erica B. Wang, Henning Stehr, James L. Zehnder, Nirasha Ramchurren, Steven P. Fling, Martin A. Cheever, Wen-Kai Weng, Youn H. Kim, Michael S. Khodadoust
Journal: Blood Advances
Blood Adv (2021) 5 (3): 771–774.
https://doi.org/10.1182/bloodadvances.2020002371
Published: 2021
Journal Articles

Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant

Pingping Zheng, John Tamaresis, Govindarajan Thangavelu, Liwen Xu, Xiaoqing You, Bruce R. Blazar, Robert S. Negrin, James L. Zehnder, Bettina P. Iliopoulou, Everett H. Meyer
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4232–4243.
https://doi.org/10.1182/bloodadvances.2019000977
Published: 2020
Includes: Supplemental data
Journal Articles

Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms

Clinical Trials & Observations
Michael A. Spinner, Alexey Aleshin, Marianne T. Santaguida, Steven A. Schaffert, James L. Zehnder, A. Scott Patterson, Christos Gekas, Diane Heiser, Peter L. Greenberg
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2768–2778.
https://doi.org/10.1182/bloodadvances.2020001934
Published: 2020
Includes: Supplemental data
Journal Articles

High-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells

Johan Jeong, Astraea Jager, Pablo Domizi, Mara Pavel-Dinu, Linda Gojenola, Masayuki Iwasaki, Michael C. Wei, Feng Pan, James L. Zehnder, Matthew H. Porteus, Kara L. Davis, Michael L. Cleary
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2825–2835.
https://doi.org/10.1182/bloodadvances.2019000450
Published: 2019
Includes: Supplemental data
Journal Articles

MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing

Corina Schneidawind, Johan Jeong, Dominik Schneidawind, In-Suk Kim, Jesús Duque-Afonso, Stephen Hon Kit Wong, Masayuki Iwasaki, Erin H. Breese, James L. Zehnder, Matthew Porteus, Michael L. Cleary
Journal: Blood Advances
Blood Adv (2018) 2 (8): 832–845.
https://doi.org/10.1182/bloodadvances.2017013748
Published: 2018
Includes: Supplemental data
Journal Articles

Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas

Alexandra Nagy, Aparna Bhaduri, Nahid Shahmarvand, Jahanbanoo Shahryari, James L. Zehnder, Roger A. Warnke, Tariq Mughal, Siraj Ali, Robert S. Ohgami
Journal: Blood Advances
Blood Adv (2018) 2 (5): 481–491.
https://doi.org/10.1182/bloodadvances.2017009654
Published: 2018
Includes: Supplemental data